GB1051686A - - Google Patents

Info

Publication number
GB1051686A
GB1051686A GB1051686DA GB1051686A GB 1051686 A GB1051686 A GB 1051686A GB 1051686D A GB1051686D A GB 1051686DA GB 1051686 A GB1051686 A GB 1051686A
Authority
GB
United Kingdom
Prior art keywords
compositions
parenterially
aprli
omithine
vasoconstrictor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of GB1051686A publication Critical patent/GB1051686A/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1051686D 1963-04-05 Active GB1051686A (US06346242-20020212-C00066.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH436163A CH421129A (de) 1963-04-05 1963-04-05 Verfahren zur Herstellung eines bisher unbekannten Polypeptids

Publications (1)

Publication Number Publication Date
GB1051686A true GB1051686A (US06346242-20020212-C00066.png)

Family

ID=4274658

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1051686D Active GB1051686A (US06346242-20020212-C00066.png) 1963-04-05

Country Status (16)

Country Link
US (1) US3299036A (US06346242-20020212-C00066.png)
AT (1) AT252474B (US06346242-20020212-C00066.png)
BE (1) BE646132A (US06346242-20020212-C00066.png)
BR (1) BR6458097D0 (US06346242-20020212-C00066.png)
CH (1) CH421129A (US06346242-20020212-C00066.png)
DE (1) DE1518269C3 (US06346242-20020212-C00066.png)
DK (1) DK112242B (US06346242-20020212-C00066.png)
ES (1) ES298271A1 (US06346242-20020212-C00066.png)
FI (1) FI42568B (US06346242-20020212-C00066.png)
FR (1) FR3926M (US06346242-20020212-C00066.png)
GB (1) GB1051686A (US06346242-20020212-C00066.png)
LU (1) LU45809A1 (US06346242-20020212-C00066.png)
MY (1) MY6900119A (US06346242-20020212-C00066.png)
NL (2) NL6403420A (US06346242-20020212-C00066.png)
OA (1) OA00697A (US06346242-20020212-C00066.png)
SE (1) SE333377B (US06346242-20020212-C00066.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH426861A (de) * 1963-06-06 1966-12-31 Sandoz Ag Verfahren zur Herstellung eines bisher unbekannten Polypeptids
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
DE3363830D1 (en) * 1982-12-21 1986-07-03 Ferring Ab Vasotocin derivatives
WO1984003279A1 (en) * 1983-02-15 1984-08-30 Armour Pharma Des-asparagine-3 calcitonin
WO1984003280A1 (en) * 1983-02-15 1984-08-30 Armour Pharma Glycine-8 calcitonin
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB802548A (en) * 1955-10-12 1958-10-08 Sandoz Ag New substance related to oxytocin and process for its preparation

Also Published As

Publication number Publication date
LU45809A1 (US06346242-20020212-C00066.png) 1964-10-03
AT252474B (de) 1967-02-27
MY6900119A (en) 1969-12-31
ES298271A1 (es) 1964-09-01
US3299036A (en) 1967-01-17
FI42568B (US06346242-20020212-C00066.png) 1970-06-01
OA00697A (fr) 1967-07-15
DE1518269C3 (de) 1973-11-08
DE1518269B2 (de) 1973-04-19
BR6458097D0 (pt) 1973-08-02
DE1518269A1 (de) 1969-11-27
SE333377B (US06346242-20020212-C00066.png) 1971-03-15
NL6403420A (US06346242-20020212-C00066.png) 1964-10-06
BE646132A (US06346242-20020212-C00066.png) 1964-10-05
FR3926M (US06346242-20020212-C00066.png) 1966-02-14
NL130081C (US06346242-20020212-C00066.png)
DK112242B (da) 1968-11-25
CH421129A (de) 1966-09-30

Similar Documents

Publication Publication Date Title
GB1330878A (en) Ketamine resolution
GB1051686A (US06346242-20020212-C00066.png)
GB1281719A (en) Anti-haemorrhoidally active preparations for local or rectal administration
GB1256723A (US06346242-20020212-C00066.png)
ES375079A1 (es) Procedimiento de fabricacion de nuevas propilaminas utilizables en terapeutica.
GB1301555A (US06346242-20020212-C00066.png)
GB1126353A (en) Isoquinolinobenzodiazepine derivatives
GB1358098A (en) Anti-inflammatory preparations containing tetrahydrocarbazole derivatives
GB1499764A (en) Polypeptides
GB1449404A (en) N-arylsulphonyl urea derivatives
ES368399A1 (es) Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilamino propanos sustituidos.
GB1225019A (en) Sulphonic acid esters
GB1451389A (en) Indolobenzazepines
GB1230705A (US06346242-20020212-C00066.png)
IE35594B1 (en) N-(bicycloamino-alkanoyl)-anilines
GB1420777A (en) Coumarin and coumarinimide compounds
GB1250598A (US06346242-20020212-C00066.png)
GB1180574A (en) Improvements in or relating to Injectable Thyroxine Preparations
GB1395929A (en) Thioureas
GB1232093A (US06346242-20020212-C00066.png)
GB1191554A (en) New Analgesic Composition.
GB1134516A (en) Antiviral compositions and treatment
GB1175590A (en) Therapeutic Compositions
GB1463908A (en) 1-dimethylamino-methyl-6-substituted-4h-s-triazolo-4,3-a- 1,4-benzodiazepine
GB1145637A (en) New sympathomimetic amine